IZOZF Company Profile and Key Details

Izotropic Corporation earnings surprise history is a mixed track record. The quarter that ended March 30, 2026, missed forecasts by -70.7%. The prior quarter beat by -12.56%. Over the last six quarters, Apple has recorded several small beats. These include -12.56% in December 29, 2025.

Average 10-day trading volume of 17.79 thousand shares is slightly above the 3-month average of 14.99 thousand, indicating heightened recent market interest.

Izotropic Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.03. This means the shares are trading below this model’s fair value.

The stock is currently mid-range between its 52-week high and low $0.10 and $0.37. With a market capitalization of about $10.49 million, Izotropic Corporation is classified as a micro-cap and shows higher-than-market volatility (beta ~2.42). Key stats such as the average daily volume over the past year has been around 13.03 thousand shares, volume is running light vs its 52-week average. Headquartered in Surrey, BC, Izotropic Corporation operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Robert Louis Thast, the company employs approximately 5 people and listed since January 08, 2021. Izotropic Corporation is a medical technology company focused on bringing advanced diagnostic solutions for breast cancer to market.

Our AI price prediction model suggests that Izotropic Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Izotropic Corporation trading at a premium to the broader market with a P/E of -6.78.

Izotropic Corporation trades at a P/E ratio of -6.78, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -2.59 indicating negative book value, which may reflect financial stress. The P/FCF stands at -18.4, also below market averages.